Last edition
News about
SmartWinnr Launches Medical Simulation to Advance AI Readiness in Pharma and Medtech
SmartWinnr has introduced a new medical simulation platform designed to help pharma and medtech companies accelerate AI readiness. Developed in collaboration with life sciences leaders and AI experts, the solution delivers clinically accurate, compliant, and emotionally intelligent training simulations for healthcare professionals.
Kiora Secures New Patent for Novel KIO-104 Formulation
Kiora Pharmaceuticals, Inc., a clinical-stage biotechnology company, announced that the US Patent and Trademark Office has issued a new patent (US-12,472,263) covering additional novel formulations within the KIO-100 family of compounds.
GSK Showcases New Advances in Blood Cancer Treatments
GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, reinforcing the potential of its therapies to redefine outcomes for patients with difficult-to-treat blood cancers.
Where Will Pharma Investments Head Next?
As India’s pharma sector shifts from a volume-driven generics model to an innovation-led ecosystem, its investment landscape is rapidly transforming. Ambitions to become a global innovation hub are pushing companies to rethink capital allocation, with R&D, manufacturing diversification, and digital transformation emerging as priorities.
Leveraging this technology, Fujitsu will begin large-scale field trials in January 2026 to optimise Rohto Pharmaceutical’s supply chain in collaboration with Science Tokyo.
MOVIN Expands into Healthcare Logistics, Launches MOVIN Healthcare
MOVIN Healthcare aims to address the critical requirements of India's growing healthcare logistics across the pharmaceutical, Medical Technology (MedTech), diagnostics and laboratory sectors.
Roche Secures FDA CLIA Waiver and CE Mark for Bordetella POC Test
Roche has received CE Mark approval for its first point-of-care test capable of diagnosing and differentiating Bordetella infections, including whooping cough, within 15 minutes. The rapid, PCR-accurate test enables faster clinical decisions and supports early intervention, particularly for vulnerable groups such as infants and the elderly.
Biomoneta's Avata Rx Becomes First Indian Air-Decontamination Technology to Receive US FDA Approval
Biomoneta, a pioneering Indian healthtech company backed by Beyond Next Ventures India (BNV India), has secured approval from the US Food and Drug Administration (US FDA) for its flagship air-decontamination system, Avata Rx. This marks the first time an Indian company has received FDA clearance in the air-decontamination category.
Celltrion Gets FDA Nod for 300mg OMLYCLO, the First Interchangeable Xolair Biosimilar
The US FDA has approved 300 mg/2 mL prefilled syringe formulation of OMLYCLO (omalizumab-igec), expanding dosing options for patients with certain allergic diseases and supporting more personalised treatment. OMLYCLO—the first and only biosimilar interchangeable with XOLAIR (omalizumab)—previously received approval for its 75 mg and 150 mg strengths.
WuXi Biologics Extends CRDMO Footprint to Qatar
WuXi Biologics has signed an MoU with the Qatar Free Zones Authority (QFZ) to expand its global footprint into the Middle East. The partnership sets the stage for the company’s first integrated CRDMO centre in the region, strengthening its worldwide research, development, and manufacturing capabilities.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy